(o) Provisions

Provisions are recognised when the Company has a present
obligation (legal or constructive) as a result of a past event,
it is probable that an outflow of resources embodying
economic benefits will be required to settle the obligation
and a reliable estimate can be made of the amount of the
obligation. When the Company expects some or all of a
provision to be reimbursed, the reimbursement is recognised
as a separate asset but only when the reimbursement is
virtually certain. The expense relating to any provision is
presented in the standalone statement of profit and loss net
of any reimbursement.

If the effect of the time value of money is material, provisions
are discounted using a current pre-tax rate that reflects,
when appropriate, the risks specific to the liability. When
discounting is used, the increase in the provision due to the
passage of time is recognised as a finance cost.

Provisions are reviewed at the end of each reporting period
and adjusted to reflect the current best estimate. If it is no
longer probable that an outflow of resources would be
required to settle the obligation, the provision is reversed.

(p) Contingent assets/liabilities

Contingent liabilities are possible obligations that arise from
past events and whose existence will only be confirmed by
the occurrence or non-occurrence of one or more uncertain
future events not wholly within the control of the Company.

Where it is not probable that an outflow of economic benefits
will be required, or the amount cannot be estimated reliably,
the obligation is disclosed as a contingent liability, unless the
probability of outflow of economic benefits is remote.

Contingent assets are not recognised. However, when
realization of income is virtually certain, then the related asset
is no longer a contingent asset, and is recognised as an asset.

(q) Income taxes

Income tax expense comprises of current tax and deferred
tax. It is recognised in the profit or loss except to the extent
that it relates to items recognised in other comprehensive
income or directly in equity.

Current tax

Current tax comprises the expected tax payable or
receivable on the taxable income or loss for the year and
any adjustment to the tax payable or receivable in respect
of previous years. The amount of current tax reflects the best
estimate of the tax amount expected to be paid or received
after considering the uncertainty, if any relating to income
taxes. It is measured using tax rates enacted for the relevant
reporting period.

Current tax assets and current tax liabilities are offset only if
there is a legally enforceable right to set off the recognised
amounts, and it is intended to realise the asset and settle the
liability on a net basis.

Deferred tax

Deferred tax is recognised in respect of temporary differences
between the carrying amounts of assets and liabilities for
financial reporting purposes and the corresponding amounts
used for taxation purposes. Deferred tax is also recognised
in respect of carried forward losses and tax credits. Deferred
tax is not recognised for temporary differences arising on
the initial recognition of assets or liabilities in a transaction
that is not a business combination and that effects neither
accounting not taxable profit or loss at the time of the
transaction.

Deferred tax liabilities are recognised for all taxable temporary
differences. Deferred tax assets are recognised to the extent
that it is probable that future taxable profits will be available
against which they can be used. The existence of unused tax
losses is strong evidence that future taxable profit may not be
available. Therefore, in case of a history of recent losses, the
Company recognises a deferred tax asset only to the extent
that it has sufficient taxable temporary differences or there
is convincing other evidence that sufficient taxable profit will
be available against which such deferred tax asset can be
realised. Deferred tax assets - unrecognised or recognised,
are reviewed at each reporting date and are recognised/
reduced to the extent that it is probable/no longer probable
respectively that the related tax benefit will be realised.

Deferred tax is measured at the tax rates that are expected
to apply to the period when the asset is realised or liability
is settled, based on the laws that have been enacted or
substantively enacted by the reporting date.

The measurement of deferred tax reflects the tax
consequences that would follow from the manner in which
the Company expects, at the reporting date, to recover or
settle the carrying amount of its assets and liabilities.

Deferred tax assets and deferred tax liabilities are offset
only if there is a legally enforceable right to offset current tax
liabilities and assets levied by the same tax authorities.

(r) Earnings per share

The Company presents basic and diluted earnings per
share (EPS) data for its equity shares. Basic EPS is calculated
by dividing the standalone Statement of profit and loss
attributable to equity shareholders of the Company by the
weighted average number of equity shares outstanding
during the year. Diluted EPS is determined by adjusting
standalone Statement of profit and loss attributable to equity
shareholders and the weighted average number of equity
shares outstanding, for the effects of all dilutive potential
equity shares, which comprise share options granted to
employees.

The number of equity shares and potentially dilutive equity
shares are adjusted retrospectively for all periods presented
for any share splits and bonus shares issues including for
changes effected prior to the approval of the standalone
financial statements by the Board of Directors.

(s) Cash and cash equivalents

Cash and cash equivalents in the balance sheet comprise
cash at banks and on hand and short-term deposits with an
original maturity of three months or less, which are subject to
an insignificant risk of changes in value.

For the purpose of the standalone statement of cash flows,
cash and cash equivalents consist of cash and short-term
deposits, as defined above.

(t) Segment reporting

An operating segment is a component of the Company that
engages in business activities from which it may earn revenues
and incur expenses, including revenues and expenses that
relate to transactions with any of the Company''s other
components, and for which discrete financial information
is available. All operating segments'' operating results are
regularly reviewed by the Company''s chief operating decision
maker to make decisions about resources to be allocated to
the segments and assess their performance. The Company''s
chief executive officer is the chief operating decision maker.

(u) Impairment of non-financial assets

The company assesses at each reporting date, whether
there is an indication that an asset may be impaired. If any
indication exists, or when annual impairment testing for
an asset is required, the company estimates the asset''s
recoverable amount. An asset''s recoverable amount is the
higher of an asset''s or cash-generating unit''s (CGU) fair
value less costs of disposal and its value in use. Recoverable
amount is determined for an individual asset, unless the asset
does not generate cash inflows that are largely independent
of those from other assets or groups of assets.

Impairment loss is recognised when the carrying amount of
an asset exceeds recoverable amount and the asset is written
down to its recoverable amount.

In assessing value in use, the estimated future cash flows are
discounted to their present value using a pre-tax discount rate
that reflects current market assessments of the time value of
money and the risks specific to the asset. In determining fair
value less costs of disposal, recent market transactions are
taken into account. If no such transactions can be identified,
an appropriate valuation model is used.

Company bases its impairment calculation on detailed
budgets and forecast calculations, which are prepared
separately for each of the CGUs to which the individual
assets are allocated. These budgets and forecast calculations
generally cover a period of five years. For longer periods, a
long-term growth rate is calculated and applied to project
future cash flows after the fifth year.

To estimate cash flow projections beyond periods covered by
the most recent budgets/forecasts, company extrapolates
cash flow projections in the budget using a steady or declining
growth rate for subsequent years, unless an increasing rate can
be justified. In any case, this growth rate does not exceed the
long-term average growth rate for the products, industries, or
country or countries in which the entity operates, or for the
market in which the asset is used.

For assets excluding goodwill, an assessment is made
at each reporting date to determine whether there is an
indication that previously recognised impairment losses
no longer exist or have decreased. If such indication exists,
the Company estimates the asset''s or CGU''s recoverable
amount. A previously recognised impairment loss is reversed
only if there has been a change in the assumptions used to
determine the asset''s recoverable amount since the last
impairment loss was recognised. The reversal is limited so
that the carrying amount of the asset does not exceed its
recoverable amount, nor exceed the carrying amount that
would have been determined, net of depreciation, had no
impairment loss been recognised for the asset in prior years.
Such reversal is recognised in the standalone statement of
profit and loss unless the asset is carried at a revalued amount,
in which case, the reversal is treated as a revaluation increase.

(v) Inventories

Inventories are valued at the lower of cost and net realizable
value in accordance with the provisions of IND AS 2.

Inventories comprise medicines, healthcare products, and
consumables used in providing Panchkarma and other
therapies/treatment services, as well as goods held for sale.

Inventories are valued at the lower of cost and net realisable
value, in accordance with Ind AS 2. Cost includes purchase
price, duties and taxes (net of recoverable taxes), freight,
and other costs incurred in bringing the inventories to their
present location and condition. Cost is determined using the
First-In-First-Out method.

Medicines and other items held for sale are recognised as
inventory and expensed to cost of goods sold upon sale.

Consumables used in rendering panchkarma, and related
services are recognised as expenses in the period in which
such services are provided, based on actual consumption.

Net realisable value is estimated based on the expected
selling price in the ordinary course of business, less estimated
costs necessary to make the sale. The Company evaluates
inventories at each reporting date for obsolescence, expiry,
and slow-moving items, particularly for medicines with
limited shelf life, and provides for diminution in value, where
necessary.

(w) Events occurring after the Balance Sheet
date

Impact of events occurring after the balance sheet date
that provide additional information materially effecting the
determination of the amounts relating to conditions existing
at the balance sheet date are adjusted to respective assets
and liabilities.

(x) New and amended standards adopted by the
Company

The Company applied for the first-time certain standards
and amendments, which are effective for annual periods
beginning on or after 1 April 2025. The Company has not early
adopted any standard, interpretation or amendment that has
been issued but is not yet effective.

The Ministry of Corporate Affairs ("MCA") notifies
amendments to Indian Accounting Standards (''lnd AS'') from
time to time under Section 133 of the Companies Act, 2013,
read with the Companies (Indian Accounting Standards)
Rules, 2015.

Standards and amendments effective for the year ended 31
March 2026 The following amendments became effective
for annual reporting periods beginning on or after 1 April 2025
and have been applied by the Company where relevant.

Amendments to lnd AS 21 - The Effects of Changes in
Foreign Exchange Rates

The amendments prescribe accounting and disclosure
requirements in situations where a currency is not
exchangeable, including guidance on estimating the spot
exchange rate when exchangeability is lacking and related
disclosures.

Amendments to lnd AS 1 - Presentation of Financial
Statements

These amendments clarify the principles for classification
of liabilities as current or non-current, particularly in relation
to the assessment of the right to defer settlement and the
impact of covenants.

Amendments to lnd AS 12 - lncome Taxes

The amendments introduce a temporary exception from
the recognition of deferred tax assets and liabilities arising
from the OECD''s Pillar Two global minimum tax regime and
prescribe additional disclosures relating to exposure to such
taxes.

Amendments to lnd AS 7 - Statement of Cash Flows
and lnd AS 107 - Financial lnstruments: Disclosures

These amendments introduce enhanced disclosure
requirements for supplier finance arrangements.

lnd AS 19 - Employee Benefits and Labour Codes

During the year, the Government of lndia implemented the
Code on Wages, 2019; the Code on Social Security, 2020; The
Industrial Relations Code, 2020 and the Occupational Safety,
Health and Working Conditions Code, 2020 with effect from
2l November 2025.

The Company has evaluated the impact of the above
amendments and concluded that they do not have any
material impact on the Company''s financial statements for
the year ended 31 March 2026, considering the nature and
extent of the Company''s operations.

Standards issued but not yet effective lnd AS 1 -
Presentation of Financial Statements.

lf covenant breach occurs on or before the reporting date
and the liability becomes payable on demand, it must
be classified as current, even if the lender subsequently
agrees not to demand repayment. lt is classified as current
because, at the reporting date, the entity does not have the
right to defer settlement for at least 12 months. However,
if the lender has already provided by the reporting date, a
grace period extending at least 12 months beyond that date,
during which the breach can be rectified and repayment
cannot be demanded, the liability is classified as non¬
current. This amendment is to be applied retrospectively for
annual reporting periods beginning on or after 1 April 2026,
in accordance with lnd AS 8, Accounting Policies, Changes in
Accounting Estimates and Errors.

Note - Impairment tests for goodwill:

The Company tests cash-generating units with goodwill annually for impairment, or more frequently if there is an indication that
a cash-generating unit to which goodwill has been allocated may be impaired. The recoverable amount of a cash generating
unit is the higher of the cash-generating unit''s fair value less cost of disposal (''FVLCD'') and its value-in-use.

For the purpose of annual impairment testing, goodwill is allocated to the operating segments expected to benefit from the
synergies of the business combinations in which the goodwill arises as set out below, and is compared to its recoverable value:

Calculation of the value-in-use is based on cash flow
projections on reasonable and supportable assumptions
that represent economic conditions that will exist over
the remaining useful life of the assets, approved by the
management, but shall exclude any estimated future
cash inflows or outflows expected to arise from future
restructurings or from improving or enhancing asset
performance.

As at 31 March 2026, the Company held goodwill of 5 5,811.82
lakhs attributable to identified Cash Generating Units (CGUs)
resulting from the acquisition of business of Oregano Life
Private Limited. Refer Note 45 for further details.

For CGU/Group of CGU''s containing goodwill at the
core business level, management conducts impairment
assessment and compares the carrying amount of such CGU/
Group of CGU''s with its recoverable amount. Recoverable
amount is value in use of the CGU/Group of CGU''s computed
based upon discounted cash flow projections for 5 years. The
key assumptions used for computation of value in use are the
growth rate and discount rate as specified below. The key
assumptions have been determined based on management''s
calculations after considering, past experiences and other
available internal information and are consistent with external
sources of information to the extent applicable.

Growth rates:

Projections are based on the budgets/forecasts using a
steady growth rate for subsequent years. In current scenario,
terminal growth rate of 4% has been derived to offset inflation,
basis past industry trend analysis.

Discount rates:

The discount rates reflect appropriate adjustments relating
to market risk and specific risk factors of each segment.
While calculating value in use discount rate of 13.55% has
been considered.

Cash flow assumptions:

The management assumed that the business will be
operated prudently and that the company shall continue to
operate and that there are no unforeseen adverse changes in
the economic conditions affecting the business, the market,
or the industry.

Key assumptions:

Key assumptions include revenue and cost synergies over
the forecast period for 5 years.

Recoverable Amount:

The recoverable amount of ''Ayurvedic Healthcare Segment''
is 5 1,78,802 lakhs which is based on value in use.

Impairment:

For CGUs/Group of CGUs containing goodwill, the impairment
assessment, taking into account above assumptions, did not
result in any impairment loss and the management believes
that any reasonably possible change in the key assumptions
would not cause the carrying amount to exceed the
recoverable amount of the said CGUs/Group of CGUs.

(ii) Terms and rights attached to equity shares

The Company has only one class of Equity Shares having a par value of t 2 per share. (31 March 2025 and 01 April 2024: t 10
per share). Each holder of Equity Shares is entitled to one vote per share. In the event of liquidation, the Equity shareholders
are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their
shareholding.

In the year ended 31 March 2022, the Company had issued bonus shares totalling to 1,00,00,080 equity shares on 25 August
2021 (90 equity shares for every one share held) and 1,10,48,954 equity shares on 03 November 2023 (4 equity shares for every
5 share held).

On 12 June 2025, the Holding Company sub-divided/split its equity shares from one equity share of face value t 10 each, fully
paid-up, into five equity shares of face value t 2 each, fully paid-up. The subdivision did not result in any change in the paid-up
share capital of the Company.

The board of directors in their meeting held on 16 May 2025 has recommended a dividend of t 5.47 (before share split) of the
face value of t 10 each for the FY 2024-25, t 1.10 (post share split) of face value of t 2 each was approved by the shareholders
in the Annual General Meeting of the Company dated 29 September 2025. The same has been paid during the year.

The board of directors of the Company at its meeting held on 30 May 2026, has recommended a final dividend of t 4.50 per
equity share to the shareholders of the Company for the year ended 31 March 2026, subject to the approval of the shareholders
in the forthcoming Annual General Meeting.

35. SEGMENT REPORTING

Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Operating Decision
Maker ("CODM") of the Company. The CODM is considered to be the one who makes strategic decisions and is responsible for
allocating resources and assessing the financial performance of the operating segments. Information reported to the CODM
for the purposes of resource allocation and assessment of segment performance focuses on the types of goods delivered or
services rendered.

With regard to the segment reporting, the Company has identified the following operating and reportable segments:

(a) Ayurvedic products/medicines

(b) Ayurvedic healthcare services

(c) Others

The Company has disclosed this Segment Reporting in Financial Statements as per Ind AS 108.

Note:

(i) No single external customer represents 10% or more of the Company''s total revenue for the year ended 31 March 2026 and
31 March 2025.

(ii) There is no inter-segment revenue for the year ended 31 March 2026 and 31 March 2025.

(iii) There is no non current asset other than financial instruments which is located outside India.

36. LEASES

The Company has leases for buildings. With the exception of short-term leases and leases of low-value underlying assets, each
lease is reflected on the balance sheet as a right-of-use asset and a lease liability. The Company classifies its right-of-use
assets in a consistent manner to its property, plant and equipment.

Lease payments to be made under reasonably certain extension options are also included in the measurement of the
lease liability. The lease payments are discounted using incremental borrowing rate of the Company, being the rate
the Company would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use
asset in a similar environment with similar terms, security and conditions. The average remaining lease term is 2.8 years
(31 March 2025: 3.8 years).

37. SHARE BASED PAYMENT

I a. Description of share based payment
arrangements- Employee Stock Option Scheme
2024

The Jeena Sikho Employee Stock Option Scheme 2024 has
been adopted by the Board of Directors on 27 February 2024,
read with the Special Resolution passed by the Members of
the Company on 27 February 2024 and shall be deemed to
come into force with effect from 27 February 2024 being
the date of approval by the Members. Pursuant to this, the
Company granted options to eligible employees at an exercise
price of 510 per option on 28 March 2024 i,e. the grant date
of the employee stock option. Each option is convertible into
one Equity Share of the Company upon vesting subject to
the Securities and Exchange Board of India (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021 and
the terms and conditions of the scheme.

The maximum number of shares that may be issued pursuant
to exercise of options granted to the participants under this
Scheme shall not exceed 6,50,000 post split (1,30,000 pre
split) shares of the Company.Subject to applicable laws,
the Company reserves the right to increase or reduce such
number of shares as it deems fit.

The maximum number of the shares that may be issued
pursuant to the grant of the options to each grantee under
ESOS 2024 shall be 100,000 (20,000 pre spilt) provided that
maximum number of shares with respect to which options
may be granted to a single employee shall not exceed 1% of
the issued capital of the Company at any point of time.

The terms and conditions of the grant as per the plan are
as under:

A. Vesting period

Vesting of the options shall take place as per the following
schedule:

- 25% of options shall vest at the end of a period of 2.5
years from date of grant

- 75% of options shall vest at the end of a period of 5
years from date of grant

B. Exercise period

The exercise period shall commence from the date of
vesting and shall close on the expiry of one year from the last
vesting date (i.e., vesting date of the second tranche) for the
respective grant of option. The employee shall have a right
to exercise all the option vested in him within the exercise
period.

Further, during the current financial year, the Company''s
equity shares were sub-divided (split) in the ratio of 1:5,
whereby one equity share of face value 510 each was split
into five equity shares of face value 52 each.

Consequent to the above sub-division and in accordance
with the terms of the ESOP Scheme and the principles of
Ind AS 102, the ESOPs outstanding were proportionately
adjusted.

Accordingly, the number of stock options outstanding
was increased, and exercise price per option was reduced
proportionately,so as to preserve the economic value of the
options granted to employees.

II a. Description of share based payment
arrangements- Employee Stock Option Scheme
2025

The Jeena Sikho Employee Stock Option Scheme 2025 has
been adopted by the Board of Directors on 29 September
2025, read with the Special Resolution passed by the
Members of the Company on 29 September 2025 and shall
be deemed to come i nto force with effect from 29 September
2025 being the date of approval by the Members. Pursuant
to this, the Company granted options to eligible employees
at an exercise price of 52 per option on 01 January 2026
and 25 March 2026 i,e. the grant date of the employee stock
option as explained in note 37(II b). Each option is convertible
into one Equity Share of the Company upon vesting subject
to the Securities and Exchange Board of India (Share Based

Employee Benefits and Sweat Equity) Regulations, 2021 and
the terms and conditions of the scheme.

The maximum number of shares that may be issued pursuant
to exercise of options granted to the participants under this
Scheme shall not exceed 2,50,000 shares of the Company.
Subject to applicable laws, the Company reserves the right
to increase or reduce such number of shares as it deems fit.

The maximum number of the shares that may be issued
pursuant to the grant of the options to each grantee under
ESOS 2025 shall be 25,000 provided that maximum number
of shares with respect to which options may be granted to a
single employee shall not exceed 1% of the issued capital of
the Company at any point of time.

V. The underlying expected volatility was determined by
reference to historical data of the Company''s shares over
a period of time since its floatation on the National Stock
Exchange. No special features inherent to the options granted
were incorporated into measurement of fair value.

38. EMPLOYEE BENEFITS

The Company has adopted Indian Accounting Standard
(Ind AS) - 19 on Employee Benefits as under:

38.1 Defined contribution plans

Provident fund

In accordance with the Employee''s Provident Fund and
Miscellaneous Provisions Act, 1952, eligible employees of
the Company are entitled to receive benefits in respect of
provident fund, a defined contribution plan, in which both
employees and the Company make monthly contributions
at a specified percentage of the covered employees'' salary.
The contributions, as specified under the law, are made to the
employee provident fund organization (EPFO).

The total expenses recognised in the statement of
profit and loss during the year on account of defined
contribution plans amounted to 5 701.24 Lakhs (31 March
2025: 5 467.62 Lakhs).

38.2 Defined obligation plans

Gratuity

The Company has an obligation towards gratuity, a defined
benefit retirement plan covering eligible employees. The plan
provides for a lump-sum payment to vested employees at
retirement, death while in employment or on termination
of employment of an amount equivalent to 26 days salary
payable for each completed year of service. Vesting occurs
upon completion of five years/one year (one year in case
of fixed term employees) of service. The Company does
not make any contributions to gratuity funds and the plan
is unfunded. The Company follows Ind AS 19 ''Employee
Benefits'' and uses Projected Unit Credit Method to value
defined benefit obligations.

The defined benefit plans expose the Company to a number of actuarial risks as below:

(a) Interest risk: A decrease in the bond interest rate will increase the plan liability.

(b) Salary risk: The present value of the defined benefit plan liability is calculated by reference to the future salaries of plan
participants. As such, an increase in the salary of the plan participants will increase the plan''s liability.

(c) Longevity risk: The present value of the defined benefit plan liability is calculated by reference to the best estimate of the
mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan''s liability.

38.3 The Government of India has consolidated 29 existing labour legislations into a united framework comprising four Labour
Codes viz Code on Wages, 2019, Industrial Relations Code, 2020, Code on Social Security, 2020, and Occupational Safety,
Health and Working Conditions Code, 2020 (collectively referred to as ''the New Labour Codes''). The New Labour Codes have
been made effective from November 21, 2025. The Ministry of Labour & Employment published draft Central Rules and FAQs
to enable assessment of the financial impact due to changes in regulations. Basis the Company''s assessment, the estimated
incremental impact amounting to 5 124.86 lacs has been recognized in the standalone statement of Profit and Loss for the year
ended 31 March 2026. The Company continues to monitor the finalization of Central/State rules and clarifications from the
Government on other aspects of the New Labour Codes and would provide appropriate accounting effect on the basis of such
developments as needed.

38.4 Other short term benefits

Compensated absences

Employee benefit expenses for the year is 33.79 lacs (31 March 2025: Nil) towards compensated absences which has been
recognised in the statement of profit and loss. Provision for compensated absences as on 31 march 2026 33.79 lacs (31 March
2025: Nil).

i) Fair value hierarchy

a. Financial assets and financial liabilities measured at fair value in the balance sheet are divided into three levels of a
fair value hierarchy. The three levels are defined based on the observability of significant inputs to the measurement,
as follows:

Level 1: Level 1 hierarchy includes financial instruments measured using quoted prices in an active market. This includes listed
equity instruments, traded debentures and mutual funds that have quoted price/declared NAV. The fair value of all equity
instruments (including debentures) which are traded in the stock exchanges is valued using the closing price as at the reporting
period.

Level 2: Level 2 hierarchy includes financial instruments that are not traded in an active market (for example, traded bonds/
debentures, over the counter derivatives). The fair value in this hierarchy is determined using valuation techniques which
maximise the use of observable market data and rely as little as possible on entityspecific estimates. If all significant inputs
required to fair value an instrument are observable, the instrument is included in level 2.

Level 3: If one or more of the significant Inputs is not based on observable market data, the instrument is included in level 3. Fair
values are determined in whole or in part using a valuation model based on assumptions that are neither supported by prices
from observable current market transactions in the same instrument nor are they based on available market data. Financial
instruments such as unlisted equity shares, loans are included in this hierarchy.

iii) Financial risk management

The Company''s activities expose it to market risk, liquidity risk and credit risk. The Company''s board of directors has
overall responsibility for the establishment and oversight of the Company''s risk management framework. This note
explains the sources of risk which the entity is exposed to and how the entity manages the risk and the related impact in
the financial statements.

a. Credit risk

Credit risk is the risk that a counterparty fails to discharge an obligation to the Company. The Company is exposed to this
risk for various financial instruments, for example by granting loans and receivables to customers, placing deposits, etc. The
Company''s maximum exposure to credit risk is limited to the carrying amount of following types of financial assets.

- cash and cash equivalents,

- trade receivables,

- loans and advances,

- investments,

- other bank balances, and

- other financial assets

Credit risk is the risk of financial loss to the Company if a
customer or counterparty to a financial instrument fails to
meet its contractual obligations, and arises principally from
the Company''s receivables from customers, loans.

Credit risk on cash and cash equivalents is limited as the
Company generally invests in deposits with banks with
high credit ratings assigned by domestic credit rating
agencies. While cash and cash equivalents are also subject
to the impairment requirements of Ind AS 109, the identified
impairment loss was immaterial.

The Company has investments in mutual funds which are
measured at fair value through profit and loss (FVTPL),
investments in subsidiaries measured at cost and investment
in LLP for which cost is considered a reasonable approximation
of fair value since the LLP is yet to commence operations
and no material events have occurred. The management
considers all these investments to have low credit risk.

The maximum exposure to the credit risk at the reporting
date is primarily from trade receivables. Trade receivables
are unsecured and are derived from revenue earned
from customers primarily located in India. For these trade
receivables, the Company does not presume significant
increase in credit risk when financial assets are past 30 days
but monitor the recoverability on case to case basis. The
Company does monitor the economic environment in which
it operates.

The Company considers the probability of default upon initial
recognition of loan and whether there has been a significant

increase in credit risk on an ongoing basis throughout each
reporting period. To assess whether there is a significant
increase in credit risk, the Company compares the risk of
a default occurring on the loan as at the reporting date
with the risk of default as at the date of initial recognition. It
considers available reasonable and supportive forwarding¬
looking information. Especially the following indicators are
incorporated:

(i) actual or expected significant adverse changes in
business, financial or economic conditions that are
expected to cause a significant change to the borrower''s
ability to meet its obligations.

(ii) actual or expected significant changes in the operating
results of the borrower.

Credit risk has always been managed by the Company
through credit approvals, establishing credit limits and
continuously monitoring the creditworthiness of customers
to which the Company grants credit terms in the normal
course of business. Credit risk in security deposits (other
financial assets) is considered to be low as they form part
of other commercial arrangements such as leases, therefore
security deposit are impaired only when there is objective
evidence of impairment. On account of adoption of Ind AS
109, the Company uses expected credit loss (ECL) model
to assess the impairment loss or gain. The Company uses
a provision matrix to compute the expected credit loss
allowance for trade receivables. The provision matrix takes
into account available external and internal credit risk factors
such as Company''s historical experience for customers.

c. Market risk - Interest rate risk

The Company''s policy is to minimise interest rate cash flow risk exposures on long-term financing. At the reporting periods
end, the Company is not exposed to changes in market interest as it does not have any variable interest rate borrowings. The
Company''s investments in fixed deposits pay fixed interest rates.

d. Market risk - Price risk

The Company''s exposure to price risk arises from investments held and classified in the balance sheet at fair value through
profit or loss. To manage the price risk arising from investments, the Company diversifies its portfolio of assets.

Sensitivity

For the listed equity securities, an average volatility of 10% has been observed during the year ended 31 March 2026 (31 March
2025: 10%). This volatility figure is considered to be a suitable basis for estimating how profit or loss and equity would have been
affected by changes in market risk that were reasonably possible at the reporting date.

41. CAPITAL MANAGEMENT POLICIES AND PROCEDURES

The Company''s objective for capital management is to maximize shareholder''s value, safeguard business continuity and
support the growth of the Company. The Company determines the capital requirement based on annual operating plan and
other strategic investment plans. The Company aims to manage its capital efficiently so as to safeguard its ability to continue
as a going concern and to optimize returns to all its shareholders. The Company''s funding requirements are met through internal
accruals. The Company is not subject to any externally imposed capital requirements.

43. CORPORATE SOCIAL RESPONSIBILITY

As per Section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend at least 2%
of its average net profit for the immediately preceding three financial years on corporate social responsibility (CSR) activities.
The areas for CSR activities are promoting health care, promoting education, rural development projects and environment
sustainability. A CSR committee has been formed by the Company as per the Act. The funds were primarily utilized throughout
the year on these activities which are specified in Schedule VII of the Companies Act, 2013.

d. The change is primarily attributable to increase in revenue from operations in the current year.

e. The change in ratio is primarily attributable to the significant increase in the revenue from operations during the year.

f. The change in ratio is primarily attributable to the increase in the profit and revenue during the current year in comparison
to the previous year.

g. The change in ratio is primarily attributable to increase in earnings before interest and taxes in comparison to the
previous year.

h. The change in ratio is primarily attributable to the increase in the actual investment against income generated from
invested funds.

45. BUSINESS COMBINATION
a. Summary of acquisition

On 3^rd October, 2024, the Company acquired five branches consisting of Ayurvedic Therapy Centres from another Company
named Oregano Life Private Limited as a going concern for a consolidated price of 5 6,915.70 lakhs.

The five branches acquired are at locations - Kishan Kunj (Delhi), Mayur Vihar (Delhi), Jothwara (Rajasthan), Alwar (Rajasthan)
and Sanganer (Rajasthan).

The aforementioned acquisition is being accounted for as a business combination in accordance with Ind AS 103 — Business
Combinations, whereby the identifiable assets acquired and liabilities assumed are recognised at their respective fair values as
at the acquisition date. The excess of the consideration transferred over the net fair value of identifiable assets and liabilities, if
any, is recognised as goodwill.

Goodwill in acquisition represents residual asset value attributable to unidentified intangible assets acquired by acquirer.
It will not be deductible for tax purposes and it will be tested for impairment annually as required by IND AS 36. (Refer Note
5 to these financial statements for impairment assessment).

b. Revenue and profit contribution

The acquired business contributed revenue of 5 802.76 lakhs and profit of 5 306.61 lakhs to the Company for the year ended
31 March 2025.

If the acquisitions had taken place on 1 April 2024, standalone revenue from operations and profit for the year ended 31 March
2025 would have been 5 48,108.47 lakhs and 5 11,215.72 lakhs respectively.

46. FIRST TIME ADOPTION OF IND AS

These are the Company''s first financial statements prepared in accordance with Ind AS. For the year ended 31 March 2025,
the Company prepared its financial statements in accordance with accounting standards referred to in paragraph 7 of the
Companies (Accounts) Rules, 2014 (Previous GAAP) notified under section 133 of the Companies Act, 2013.

The accounting policies set out in note 2 have been applied
in preparing the financial statements for the year ended 31
March 2026, the comparative information presented in these
financial statements for the year ended 31 March 2025 and in
the preparation of opening IND AS balance sheet at 01 April
2024 (the Company''s date of transition).

In preparing its IND AS balance sheet as at 01 April 2024 and
in presenting the comparative information for the year ended
31 March 2025, the Company has adjusted its amounts
reported previously in the financial statements prepared in
accordance with previous GAAP.

Accordingly, the Company prepared first Ind AS financial
statements which comply with Ind AS applicable for period
ending on 31 March 2026, together with the comparative
period data as at and for the year ended 31 March 2025, with
a Ind AS transition date of 1 April 2024. This note explains the
principal adjustments made by the Company in restating its
financial statements prepared in accordance with previous
GAAP and an explanation of how the transition from previous
GAAP to Ind AS has affected the Company''s financial
position, financial performance and cash flows is set out in
the following tables and notes.

A. Ind AS optional exemptions

1. Deemed cost for property, plant and equipment
and intangible assets

Ind AS 101 permits a first-time adopter to elect to continue
with the carrying value for all of its property, plant and
equipment as recognised in the financial statements as at
the date of transition to Ind AS, measured as per the Previous
GAAP and use that as its deemed cost as at the date of
transition after making necessary adjustments for de¬
commissioning liabilities. This exemption can also be used
for intangible assets covered by Ind AS 38 Intangible Assets.
Accordingly, the Company has elected to measure all of its
property, plant and equipment and intangible assets at their
Previous GAAP carrying value.

2. Impairment of financial assets

At the date of transition to Ind AS, determining whether there
has been a significant increase in credit risk since the initial
recognition of a financial instrument would require undue
cost or effort, the Company has recognised a loss allowance
at an amount equal to lifetime expected credit losses at each
reporting date until that financial instrument is derecognised.

3. Leases

The Company has elected to measure the right of use
assets at the date of transition an amount using modified
retrospective approach, adjusted by the amount of any
prepaid or accrued lease payments relating to that lease
recognised in the Balance Sheet immediately before the date
of transition to Ind AS. Further, the following expedients were
used on transition to Ind AS:

- the use of a single discount rate to a portfolio of leases
with reasonably similar characteristics.

- the accounting for operating leases with a remaining
lease term of less than 12 months as on the transition
date as short-term leases.

- the exclusion of initial direct costs for the measurement
of the right of use asset at the date of initial application.

- use of hindsight, such as in determining the lease term
as the contract contains the options to extend and
terminate the lease.

B. Ind AS mandatory exceptions

1. Estimates

An entity''s estimates in accordance with Ind ASs at the date
of transition to Ind AS shall be consistent with estimates made
for the same date in accordance with Previous GAAP (after
adjustments to reflect any difference in accounting policies),
unless there is objective evidence that those estimates were
in error.

Ind AS estimates as at 1 April 2024 are consistent with
the estimates as at the same date made in conformity
with Previous GAAP. The Company made estimates for
impairment of financial assets based on expected credit loss
model in accordance with Ind AS at the date of transition as
these were not required under Previous GAAP.

2. Classification and measurement of financial assets
and liabilities

The classification and measurement of financial assets and
financial liabilities will be made considering whether the
conditions as per Ind AS 109, "Financial Instruments", are met
based on facts and circumstances existing at the date of
transition.

Financial assets can be measured using effective interest
method by assessing its contractual cash flow characteristics
only on the basis of facts and circumstances existing at the
date of transition and if it is impracticable to assess the
elements of modified time value of money, i.e., the use of
effective interest method, fair value of financial asset at the
date of transition shall be the new carrying amount of that
asset. The measurement exemption applies for financial
liabilities as well.

Applying a requirement is impracticable when the entity
cannot apply it after making every reasonable effort to do so.
It is impracticable to apply the:

(a) The effects of the retrospective application or
retrospective restatement are not determinable;

(b) The retrospective application or restatement requires
assumptions about what management''s intent would
have been in that period.

The retrospective application or retrospective restatement
requires significant estimates of amounts and it is impossible
to distinguish objectively information about those estimates
that existed at that time.

Notes

(a) Under previous IGAAP, goodwill was amortized over the period in which the economic benefit from the acquired business
is expected to flow to the Company and intangible assets were amortized based on the assesed usefule life. The Company
has reassessed the useful life of goodwill and determined that it has an indefinite useful life. Goodwill and intangible
assets with indefinite life are not amortized under Ind AS. Instead, goodwill is subject to an annual impairment test and the
assumption of indefinite life of intangible assets reviewed annually. Accordingly the amortization charge under previous
IGAAP has been adjusted.

Goodwill has been recomputed during the year based on the purchase price allocation (PPA) as per Ind AS. Under Ind
AS, goodwill is determined based on purchase price allocation, which involves allocating the consideration paid to the
identifiable assets and liabilities at fair value. Accordingly, goodwill has been recomputed during the transition.

(b) Provision for Gratuity is recomputed based on actuarial valuation under Ind AS, resulting in adjustment to employee benefit
obligations. The acturial gain/loss have been transferred to Other Comprehensive Income (OCI) net of tax intead of profit
and loss as prescribed by the IND AS.

(c) Employee stock expenses has been recorded based on
the fair value of the options at grant date under Ind AS.

(d) The Company has valued its financial assets (current
investment) at fair value.The impact for change in fair
value as on date of transition (i.e., 01 April 2024), is
recognized in opening equity and changes thereafter
are recognized in the Statement of Profit and Loss or
OCI based on the classification of same.

(e) Under previous IGAAP, rent payments were charged to
the Statement of Profit and Loss. Under Ind AS, for long¬
term and high-value leases, a Right-of-Use (ROU) asset
and corresponding lease liability are recognized. The
ROU asset is amortized over the lease term, and interest
on the lease liability is recorded in the Statement of
Profit and Loss, replacing the earlier rent expense.

(f) Expected credit losses are recognized for all financial
assets subsequent to initial recognition other than
financial assets in FVTPL category.The impairment
losses and reversals are recognised in Statement of
Profit and Loss.

(g) The impact of transition adjustment together with
Ind-AS mandate of using balance sheet approach
for computation of deferred taxes has resulted in
charge to the reserves, on the date of transition, with
consequential impact to the Profit and Loss Account for
the subsequent periods.

(h) Figures have been regrouped/re-classified of previous
periods wherever necessary for better presentation and
disclosures and the same are not considered material to
these financial statements.

The transition from previous GAAP to Ind AS has not made a
material impact on the statement of cash flows.

47. ADDITIONAL INFORMATION NOT
DISCLOSED ELSEWHERE IN THE FINANCIALS
STATEMENTS

(a) Borrowing secured against current assets

The Company does not have borrowings from financial
institutions on the basis of security of current assets.

(b) Benami Property

The Company does not have any benami property, where
any proceeding has been initiated or pending against the
Company for holding any Benami property.

(c) Willful defaulter

The Company is not declared a willful defaulter by any bank
or financial institution or any other lender.

(d) Relationship with struck off companies

The Company has not entered into any transactions with
companies struck off under section 248 of the Companies
Act, 2013 or section 560 of Companies Act, 1956.

(e) Compliance with number of layers of
companies

The Company has complied with the number of layers
prescribed under section 2(87) of the Companies Act, 2013
read with Companies (Restriction on number of Layers)
Rules, 2017.

(f) Compliance with approved scheme(s) of
arrangements

The Company has not entered into any scheme of
arrangement which has an accounting impact on current or
previous financial years.

(g) Registration of charges or satisfaction with
Registrar of Companies

The Company does not have any charges or satisfaction
which is yet to be registered with ROC beyond the statutory
period.

(h) Details of funds advanced or loaned or invested
in intermediaires and further invested or loaned by
intermediaries:

(i) The Company has not advanced or loaned or invested
funds to any other persons or entities (other than the
transactions as disclosed below), including foreign
entities (Intermediaries) with the understanding that the
Intermediary shall:

(a) directly or indirectly lend or invest in other persons
or entities identified in any manner whatsoever
by or on behalf of the Company (Ultimate
Beneficiaries); or

(b) provide any guarantee, security or the like to or on
behalf of the Ultimate Beneficiaries.

(ii) The Company has not received any fund from any persons
or entities, including foreign entities (Funding Party) with the
understanding (whether recorded in writing or otherwise)
that the Company shall:

(a) directly or indirectly lend or invest in other persons or
entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of
the Ultimate Beneficiaries

Mar 31, 2025